Teri Loxam | IR |
Ken Frazier | Chairman and CEO |
Rob Davis | CFO |
Roger Perlmutter | President, Merck Research Labs |
Frank Clyburn | CCO |
Seamus Fernandez | Guggenheim |
Steve Scala | Cowen |
Andrew Baum | Citi |
Chris Schott | JPMorgan |
David Risinger | Morgan Stanley |
Umer Raffat | Evercore ISI |
Tim Anderson | Wolfe Research |
Vamil Divan | Credit Suisse |
Jason Gerberry | Bank of America |
Alex Arfaei | BMO Capital Markets |
Geoff Meacham | Barclays |
Good morning. My name is Darla, and I will be your conference operator today. At this time, I would like to welcome everyone to Merck's Fourth Quarter 2018 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.